Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT07174336 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 800 participants |
| Active Locations | 129 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | October 8, 2026 (4 days ago) |
As of October 12, 2026: Clinical trial NCT07174336 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 129 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07174336 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 129 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07174336 was last updated 4 days ago (October 8, 2026). HelloStudys verifies this status automatically.